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The first published report of an association between alcohol
consumption and breast cancer risk was by Williams and Horm
(1977). This investigation was hypothesis-generating, however, in
that it examined multiple potential risk factors for several cancers
and, apart from age, ethnic group and smoking habits, no account
was taken of other potential confounding variables. A possible
association between breast cancer and tobacco smoking was first
proposed by Macmahon et al (1982). They hypothesised that cigar-
ette smoking would reduce the risk of breast cancer, mainly on the
basis of their observation that smoking was associated with a
reduction in urinary oestrogen levels during the luteal phase of
the menstrual cycle. However, Hiatt and Fireman (1986) proposed
a contrary hypothesis. They postulated that tobacco smoke would
have a direct carcinogenic effect as mutagens from cigarette smoke
had been found in the breast fluid of non-lactating women.
Since these initial reports, a substantial number of epidemiolo-
gical investigations have assessed these hypotheses. The overall
evidence from the epidemiological data published so far seems to
indicate that alcohol intake may be associated with a slight increase
in the risk of breast cancer. By contrast, the evidence for smoking
has been rather inconsistent, with some studies showing a slight
increase in risk and others reporting no association or, even, a
protective effect. Most of these studies have been based on rela-
tively small numbers of breast cancer cases, however, thus
yielding rather imprecise estimates of the true effects of these expo-
sures. In addition many of them were unable to take account of the
fact that alcohol and tobacco consumption are correlated, as
smokers are more likely to drink alcohol than non-smokers.
Clarification of the independent effects, if any, of these expo-
sures on the risk of breast cancer is of epidemiological relevance
for various reasons. First, for populations where the prevalence
of alcohol and/or tobacco consumption is high, even if the relative
risk associated with these exposures is small, the effect of these
exposures could still account for a substantial number of breast
cancer cases. Second, unlike most of the known risk factors for
breast cancer, alcohol and tobacco consumption are potentially
modifiable behaviours and hence offer some scope for prevention.
Third, clarification of the aetiological role of these exposures might
shed light on the biology of breast cancer.
In this issue, the Collaborative Group on Hormonal Factors in
Breast Cancer (2002) has published a reanalysis of individual data
from over 80% of the worldwide epidemiological information on
alcohol, tobacco and breast cancer risk in women. This reanalysis
of data from 53 different studies, which included 58 515 women
with breast cancer and 95 067 without, showed that the relative risk
of breast cancer increased by 7.1% for each additional 10 g day71
intake of alcohol, i.e. for each extra unit (alcoholic drink)
consumed on a daily basis. Relative to women who reported drink-
ing no alcohol, the risk of developing breast cancer was 32% higher
among those who reported drinking 35 – 44 g day71 and 46%
higher among those who reported consuming 45 g day71 or more
(average 57 g day71). The effect of alcohol was not found to be
confounded by smoking or by any other known risk factor for
breast cancer. The authors estimated that in developed countries
the cumulative incidence of breast cancer by age 80 would be 8.8
per 100 women in non-drinkers and 9.4, 10.1, 10.8, 11.6, 12.4
and 13.3, respectively, per 100 women among women consuming
an average of 1, 2, 3, 4, 5 and 6 alcoholic drinks each day. By
contrast, the relationship between smoking and breast cancer was
substantially confounded by the effect of alcohol and when the
analysis was restricted to non-drinkers, no association was found
between smoking and breast cancer.
So, can we now finally pass judgement on the alcohol- and
tobacco-breast cancer hypotheses and lay them to rest? Unfortu-
nately, the answer is not yet. As acknowledged by the authors
the quality and validity of their exposure data were, to a certain
extent, limited, as most of the individual studies were not set up
with the primary purpose of addressing these hypotheses. Despite
this caveat, the results strongly argue against an association
between smoking and breast cancer but are in favour of a true
positive association between alcohol and this tumour. Given the
impossibility of conducting a randomised trial on this issue a
causal relation between alcohol and breast cancer can never be
established beyond any doubt, but the evidence provided by this
reanalysis of practically all the available worldwide data, and the
consistency of the findings across the various studies, strongly
suggest that something is going on. As the relative risks involved
are modest, it could be argued that the observed relationship
between alcohol and breast cancer might be due to confounding
by unknown risk factors, but it is hard to envisage an as yet
unknown risk factor, which is consistently associated with alcohol
intake in the relatively diverse populations studied.
Even if causal, the exact relationship with duration, timing, or
indeed amount, of alcohol intake remains unclear. Self-reported
information on alcohol consumption is known to be prone to
measurement error and it is uncertain to what extent this mightReceived 12 September 2002; accepted 12 September 2002
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have affected the magnitude and shape of the dose – response rela-
tionship. Thus, a degree of uncertainty remains about the true
quantitative effect of a given amount of alcohol on the risk of
developing breast cancer, and in particular, whether there may be
a threshold dose below which alcohol has no effect. The tendency
for underestimation of the amount drunk and concerns that non-
drinkers may differ in some relevant, but unmeasured, ways from
those who occasionally drink alcohol, precludes an accurate estima-
tion of the risks associated with low levels of alcohol intake.
Should the advice to women change in the light of the findings
from this reanalysis? After assimilating the new findings the answer
is probably no. In terms of public health, both factors are already
known to be important for women’s health. Smoking has already
been shown to cause many fatal diseases, particularly lung cancer
and coronary heart disease. The implications of the findings for
alcohol are less straightforward. In this reanalysis, the average
consumption of alcohol reported by controls from developed
countries was 6.0 g day71. On the basis of the observed dose –
response relationship, and assuming causality, the authors esti-
mated that about 4% of all breast cancer cases in developed
countries are attributable to alcohol. In developing countries,
where the average alcohol consumption is very low (only 0.4 g
day71), alcohol would make a negligible contribution to the total
number of cases of breast cancer. To put these figures into perspec-
tive, up to 90% of all lung and cervical cancers can be attributed to
smoking and infection with human papillomavirus (HPV), respec-
tively.
Complete elimination of alcohol consumption is neither feasi-
ble nor justified in health terms. We know from other studies
that women who drink alcoholic beverages regularly have higher
death rates from injuries, violence, suicide, poisoning, cirrhosis,
certain cancers (namely cancers of the oropharynx, larynx, oeso-
phagus and liver), and possibly haemorrhagic stroke, but lower
death rates from coronary heart disease and thrombotic stroke
compared with those who abstain completely (Thun et al,
1997). The net balance of risks and benefits associated with alco-
hol intake is, therefore, complex. The American Cancer Society
(ACS) study of half a million people who have been followed
since 1982, suggests that all-cause mortality rates are 20% lower
among middle aged women who drink one alcoholic drink per
day relative to those who abstain, and only begin to show an
increase at around two drinks per day (Thun et al, 1997). In a
recent evaluation of alcohol-related mortality in England and
Wales (Britton and Mcpherson, 2001), a net protective mortality
balance could only be found among women aged over 65 years,
the age after which the risk of coronary heart disease is highest.
By contrast, breast cancer was one of the top three causes of alco-
hol related deaths in younger women together with alcoholic liver
diseases and suicide. It has been estimated that the most beneficial
drinking levels in terms of lowest risk of death for women in
England and Wales would be zero consumption at ages 16 to
54 years, rising to 3 units per week in those aged over 65 years
(White et al, 2002), but these estimates do not allow for the fact
that many alcohol-related effects, including the cardioprotective
ones, may require exposure over several years before becoming
apparent.
The answer to the initial question ‘Should alcohol be
condemned and tobacco acquitted?’ will depend on whether this
is primarily an aetiological or a public health question. In terms
of breast cancer aetiology, this reanalysis provides strong evidence
that alcohol, rather than smoking, is the culprit. And yet, in public
health terms, there is no doubt that tobacco should be condemned
as it was responsible for an average of about 3 million deaths per
year worldwide during the 1990s and, if nothing is done to change
current smoking patterns, this figure may well rise to 10 million
deaths per year by the 2020s (Peto et al, 1994). Alcohol intake,
on the other hand, is likely to account, at present, for a small
proportion of breast cancer cases in developed countries, but for
women who drink moderately, its lifetime cardioprotective effects
probably outweigh its health hazards.
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